Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Vladimir Spiegelman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting ß-TrCP regulators to improve CRC response to chemotherapy
Spiegelman, V. (PI) & Fuchs, S. S. Y. (CoPI)
3/5/24 → 2/28/26
Project: Research project
-
Role and mechanisms of IGF2BP1 in melanoma pathogenesis
Spiegelman, V. (PI)
12/2/19 → 11/30/23
Project: Research project
-
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis
Spiegelman, V. S. (PI) & Spiegelman, V. (CoPI)
12/1/14 → 11/30/15
Project: Research project
-
RNA-binding protein CRD-BP in melanocyte biology
Spiegelman, V. (PI) & Spiegelman, V. S. (CoPI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
2/11/13 → 1/31/19
Project: Research project
-
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers
Spiegelman, V. S. (CoPI) & Spiegelman, V. (PI)
3/1/07 → 1/31/13
Project: Research project
-
Chemotherapy-induced small extracellular vesicles prime the pre-metastatic niche to accelerate neuroblastoma metastasis
Wills, C. A., Liu, X., Chen, L., Zhao, Y., Liu, Z., Spiegelman, V. S., Sundstrom, J. & Wang, H. G., Jul 2024, In: Genes and Diseases. 11, 4, 101017.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Development of a specific and potent IGF2BP1 inhibitor: A promising therapeutic agent for IGF2BP1-expressing cancers
Singh, A., Singh, V., Wallis, N., Abis, G., Oberman, F., Wood, T., Dhamdhere, M., Gershon, T., Ramos, A., Yisraeli, J., Spiegelman, V. S. & Sharma, A. K., Jan 5 2024, In: European Journal of Medicinal Chemistry. 263, 115940.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics
Dhamdhere, M. R. & Spiegelman, V. S., 2024, In: Frontiers in immunology. 15, 1385875.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
PARP11 inhibition inactivates tumor-infiltrating regulatory T cells and improves the efficacy of immunotherapies
Basavaraja, R., Zhang, H., Holczbauer, Á., Lu, Z., Radaelli, E., Assenmacher, C. A., George, S. S., Nallamala, V. C., Beiting, D. P., Meyer-Ficca, M. L., Meyer, R. G., Guo, W., Fan, Y., Modzelewski, A. J., Spiegelman, V. S., Cohen, M. S. & Fuchs, S. Y., Jul 16 2024, In: Cell Reports Medicine. 5, 7, 101649.Research output: Contribution to journal › Article › peer-review
Open Access -
RNA Binding Proteins as Potential Therapeutic Targets in Colorectal Cancer
Singh, V., Singh, A., Liu, A. J., Fuchs, S. Y., Sharma, A. & Spiegelman, V. S., Oct 2024, In: Cancers. 16, 20, 3502.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations